
Biofil Chemicals & Pharmaceuticals Stock Hits 52-Week Low at Rs.32.6
2025-12-03 10:17:26Biofil Chemicals & Pharmaceuticals has reached a new 52-week low of Rs.32.6, marking a significant decline in its stock price amid broader market movements and company-specific factors.
Read MoreWhy is Biofil Chemicals falling/rising?
2025-12-03 00:47:25Recent Price Movement and Market Context Biofil Chemicals’ share price has been under pressure for some time, with the stock currently trading just 1.17% above its 52-week low of ₹35.60. The intraday low on 02-Dec touched ₹35.61, marking a 5.19% decline from previous levels. This downward momentum is further underscored by the stock’s underperformance against its sector, lagging by 4.11% on the day. Additionally, the weighted average price indicates that a greater volume of shares exchanged hands near the day’s low, signalling selling pressure among investors. Technical indicators also paint a bearish picture. Biofil Chemicals is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Such positioning typically suggest...
Read More
Biofil Chemicals & Pharmaceuticals Falls to 52-Week Low of Rs.35.6
2025-11-25 10:18:43Biofil Chemicals & Pharmaceuticals touched a new 52-week low of Rs.35.6 today, marking a significant decline amid a series of consecutive trading sessions with negative returns. The stock has been under pressure, trading below all major moving averages and lagging behind its sector and benchmark indices.
Read More
Biofil Chemicals & Pharmaceuticals Falls to 52-Week Low of Rs.37.71
2025-11-24 10:42:02Biofil Chemicals & Pharmaceuticals has reached a new 52-week low of Rs.37.71, marking a significant decline in its stock price amid a period of sustained downward movement. The stock has underperformed its sector and broader market indices, reflecting ongoing challenges in its financial performance and market positioning.
Read More
Biofil Chemicals Q2 FY26: Revenue Surge Masks Profitability Collapse
2025-11-15 09:26:57Biofil Chemicals & Pharmaceuticals Ltd. reported a dramatic quarter-on-quarter revenue surge of 110.58% in Q2 FY26, with net sales reaching ₹13.54 crores compared to ₹6.43 crores in Q1 FY26. However, the seemingly positive headline numbers concealed a troubling deterioration in profitability, with net profit collapsing 96.68% to just ₹0.08 crores from ₹2.41 crores in the previous quarter. The stock, trading at ₹39.00 with a market capitalisation of ₹64.00 crores, has declined 38.56% over the past year, significantly underperforming both the Sensex and its pharmaceutical sector peers.
Read MoreHow has been the historical performance of Biofil Chemicals?
2025-11-14 23:57:00Answer: The historical performance of Biofil Chemicals shows fluctuations in net sales and profitability over the years, with a notable decline in recent periods. Breakdown: Biofil Chemicals reported net sales of 33.40 Cr in March 2025, down from 40.04 Cr in March 2024, but an increase from 30.04 Cr in March 2023. The total operating income followed a similar trend, peaking at 40.04 Cr in March 2024 and showing a decrease to 33.40 Cr in March 2025. The company's total expenditure, excluding depreciation, was 32.55 Cr in March 2025, down from 39.22 Cr in March 2024. Operating profit (PBDIT) for March 2025 was 1.16 Cr, slightly lower than 1.31 Cr in March 2024. Profit before tax decreased to 0.74 Cr in March 2025 from 0.87 Cr in March 2024, while profit after tax was 0.56 Cr in March 2025, compared to 0.71 Cr in March 2024. The company's total assets increased to 50.96 Cr in March 2025 from 47.08 Cr in March...
Read MoreHow has been the historical performance of Biofil Chemicals?
2025-11-13 23:29:33Answer: The historical performance of Biofil Chemicals shows fluctuations in net sales, operating profit, and profit after tax over the years. Breakdown: Biofil Chemicals reported net sales of 33.40 Cr in March 2025, a decrease from 40.04 Cr in March 2024, but an increase from 30.04 Cr in March 2023. The total operating income followed a similar trend, with figures of 33.40 Cr in March 2025, 40.04 Cr in March 2024, and 30.04 Cr in March 2023. The total expenditure, excluding depreciation, was 32.55 Cr in March 2025, down from 39.22 Cr in March 2024 and up from 28.87 Cr in March 2023. Operating profit (PBDIT) for March 2025 was 1.16 Cr, slightly lower than 1.31 Cr in March 2024, and 1.27 Cr in March 2023. Profit before tax was 0.74 Cr in March 2025, down from 0.87 Cr in March 2024, while profit after tax was 0.56 Cr, compared to 0.71 Cr in the previous year. Total assets increased to 50.96 Cr in March 2025 ...
Read MoreWhy is Biofil Chemicals falling/rising?
2025-11-06 22:26:38As of 06-Nov, Biofil Chemicals & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 38.60, which reflects a decrease of 1.0 (-2.53%). The stock has been underperforming, having fallen for the last two days with a total decline of -5.14% during this period. It is also trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, the stock is close to its 52-week low, being only 1.55% away from that point. The delivery volume has significantly decreased by -71.26% compared to the 5-day average, suggesting a drop in investor participation, which could further contribute to the stock's downward movement. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's performance. In the broader market context, Biofil Chemicals has shown a negative return of -6.15% o...
Read More
Biofil Chemicals Hits 52-Week Low as Stock Plummets to Rs 38
2025-11-06 11:37:12Biofil Chemicals & Pharmaceuticals has reached a 52-week low, reflecting a significant decline in its stock price. The company has underperformed its sector and consistently traded below key moving averages. Despite some positive quarterly results, long-term fundamentals indicate weak growth, posing challenges for the company.
Read MoreCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
02-Jan-2026 | Source : BSECertificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 for the quarter ended on 31st December2025
Closure of Trading Window
23-Dec-2025 | Source : BSEIntimation of closure of Trading window with effect from Thursday 01st January 2026.
Receipt Of Fine From BSE Limited.
03-Dec-2025 | Source : BSEReceipt of Fine from BSE Limited
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available